Improving Access to New Medicines

Canadians wait too long – but we’re working to speed up the process.

The Problem

Even after a treatment is approved by Health Canada, it can take more than two years before it becomes available through public drug plans. That’s significantly longer than in most peer countries, placing Canada last among G7 nations. In addition, fewer than 20 per cent of new medicines launched globally are available on Canadian public plans.

The Problem

The Impact

The delayed availability of medicines and treatments comes at a real cost:

Missed Opportunities

Canadians miss out on new treatments that could improve or save lives.

Fewer Options

Patients have fewer treatment options compared to those in other countries.

Less Investment

Canada becomes a less attractive destination for life sciences investments and clinical trials.

System Strain

The health system is further strained by outdated treatments.

Missed Opportunities

Canadians miss out on new treatments that could improve or save lives.

Fewer Options

Patients have fewer treatment options compared to those in other countries.

Less Investment

Canada becomes a less attractive destination for life sciences investments and clinical trials.

System Strain

The health system is further strained by outdated treatments.

The Solution

We believe Canadians deserve timely access to the best available treatments. We’re advocating for a smarter, more coordinated approach that includes:

The Solution

We believe Canadians deserve timely access to the best available treatments. We’re advocating for a smarter, more coordinated approach that includes:

Better collaboration between industry and government.

Modernized health technology assessment processes.

Systems that prioritize speed and patient outcomes.

Clearing regulatory backlogs.

Join the Community

First Name(Required)

Last Name(Required)

Email(Required)

Phone

Postal Code(Required)

Province/Territory(Required)

By signing up, you agree to receive periodic emails from Medicine Matters Canada containing news, updates, and ways to get involved. Medicine Matters Canada is an initiative of Innovative Medicines Canada (“IMC”). These emails may be sent on IMC’s behalf by our service provider. You can unsubscribe at any time. Contact: Innovative Medicines Canada | 310-99 rue Bank St. Ottawa, ON K1P 6B9 | info@imc-mnc.ca